Vitamin Intervention for Stroke Prevention Trial - 0 views
-
Nathan Goodyear on 25 Jul 12Vitamin B12, methyl cobalamin, is very important in lowering homocysteine levels through methionine synthase. The VISP trial did not show efficacy in the intention to treat analysis. However, analysis of the efficacy reveals that many clients had too low of vitamin B12 levels due to malabsorption and vitamin B12 levels should have been higher in the VISP intention to treat.